Skip to main content
    O

    Option Care Health Inc (OPCH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $31.63
    -0.08 (-0.25%)

    Market Cap: $4.75B

    Last updated: Nov 17, 2026 at 4:21 PM ET

    Option Care Health Inc (OPCH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Option Care Health (OPCH) has a market cap of $4.75B and an enterprise value of $5.61B. Its share count is down 7.44% from a year earlier. Its trailing P/E of 18.5x is below its 5-year median of 25.7x.

    Total Valuation

    Enterprise value is 18.08% above the market cap, as debt exceeds cash.

    Market Cap$4.75B
    Enterprise Value$5.61B
    Latest price (Nov 17, 2026)$31.63

    Key Dates

    The next earnings report is expected on Jan 11, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateJan 11, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 2.06% in the quarter ended Sep 30, 2026 and shrank 6.31% a year over 2 years.

    Shares Outstanding149.79M
    Shares Change (YoY)-7.44%
    Shares Change (QoQ)-2.06%
    Share Count Growth (2Y CAGR)-6.31%

    Valuation Ratios

    Sales and book value multiples are 0.8x and 3.6x. Its year-end P/E ranged from 18.1x to 142.2x from 2020 to 2025.

    P/E Ratio18.5x
    Forward P/E16.4x
    P/S Ratio0.8x
    Forward P/S0.8x
    P/B Ratio3.6x
    P/FCF Ratio16.8x
    P/OCF Ratio14.7x
    PEG Ratio1.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 13.4x EBITDA and 19.9x free cash flow.

    EV / Earnings26.1x
    EV / Sales1.0x
    EV / EBITDA13.4x
    EV / EBIT16.4x
    EV / FCF19.9x

    Price Statistics

    The stock is up 11.33% over 52 weeks and trades 11.45% above its 50-day average.

    Beta (1Y)-0.02
    52-Week Change+11.33%
    1-Month Change+1.35%
    3-Month Change+35.46%
    6-Month Change+51.63%
    5-Year Change+16.47%
    10-Year Change+195.82%
    Total Return (1Y)+11.33%
    Total Return (3Y CAGR)+2.57%
    Total Return (5Y CAGR)+3.57%
    Return vs SPY (1Y)+0.29%
    Max Drawdown (1Y)-46.65%
    Max Drawdown (3Y)-46.65%
    Sharpe Ratio (1Y)0.22
    Correlation with SPY (1Y)-0.01
    50-Day Average$28.38
    200-Day Average$26.09
    52-Week Range$18.01 to $36.80
    RSI (14 Days)72.3
    Average Volume (20 Days)3.52M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.54x current liabilities, and total debt is 0.87x shareholder equity.

    Current Ratio1.54x
    Quick Ratio1.06x
    Debt / Equity0.87x
    Debt / EBITDA2.77x
    Debt / FCF4.11x
    Interest Coverage6.45x

    Returns and Efficiency

    Return on invested capital is 10.02% over the last 12 months, against a 5-year average of 9.41%.

    Return on Equity (ROE)16.25%
    Return on Assets (ROA)6.19%
    Return on Invested Capital (ROIC)10.02%
    Return on Capital Employed (ROCE)13.00%
    ROE (5Y Average)14.46%
    ROA (5Y Average)6.07%
    ROIC (5Y Average)9.41%
    Asset Turnover1.65x
    Inventory Turnover11.53x
    Receivables Turnover11.31x
    Cash Conversion Cycle13 days

    Taxes

    Income tax took 27.15% of pretax income over the last 12 months.

    Income Tax (TTM)$80.21M
    Effective Tax Rate27.15%

    Scores

    OPCH has an Altman Z-Score of 3.88, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score3.88
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $5.75B over the last 12 months is up 4.01% from the 12 months before.

    Revenue$5.75B
    Revenue Growth (YoY)+4.01%
    Gross Profit$1.10B
    Operating Income$338.40M
    Pretax Income$295.41M
    Net Income$215.19M
    EBITDA$417.28M
    EBIT$341.31M
    Reported EPS (TTM)$1.71

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 37.93% of the $3.48B in total assets.

    Cash and Equivalents$299.09M
    Total Debt$1.16B
    Net Debt$858.74M
    Net Debt Per Share$5.73
    Working Capital$461.56M
    Shareholder Equity$1.32B
    Book Value Per Share$8.84
    Tangible Book Value-$563.63M
    Total Assets$3.48B
    Total Liabilities$2.15B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $40.45M of capital spending, operating cash flow left $281.65M of free cash flow.

    Operating Cash Flow$322.10M
    Capital Expenditures$40.45M
    Free Cash Flow$281.65M
    FCF Per Share$1.88
    Depreciation and Amortization$75.97M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 5.88%, against a 5-year average of 6.27%.

    Gross Margin19.07%
    Operating Margin5.88%
    Pretax Margin5.14%
    Net Margin3.74%
    EBITDA Margin7.25%
    EBIT Margin5.93%
    FCF Margin4.90%
    Gross Margin (5Y Average)21.40%
    Operating Margin (5Y Average)6.27%
    Net Margin (5Y Average)4.40%

    Growth

    Revenue grew 12.72% a year over 3 years, and EPS 27.49% a year.

    Revenue Growth (3Y CAGR)+12.72%
    Revenue Growth (5Y CAGR)+13.25%
    EPS Growth (3Y CAGR)+27.49%
    EPS Growth (5Y CAGR)+73.31%
    FCF Growth (3Y CAGR)-2.21%
    FCF Growth (5Y CAGR)+16.65%
    Operating Income Growth (3Y CAGR)+12.04%
    Book Value Per Share Growth (2Y CAGR)+1.86%

    Revenue and profit by year

    Dividends and Yields

    OPCH does not pay a dividend. Its free cash flow yield is 5.94%.

    Earnings Yield5.41%
    FCF Yield5.94%
    Buyback Yield2.01%
    Shareholder Yield2.01%

    Stock Splits

    The last split was a 1-for-4 reverse split on Feb 3, 2020.

    Last Split DateFeb 3, 2020
    Split TypeReverse split
    Split Ratio1:4

    Peer Position

    Against 12 similar companies, OPCH has the 8th highest P/E and the 10th highest P/S.

    P/E Ratio18.5x vs 21.7x median
    P/S Ratio0.8x vs 1.2x median
    ROIC10.02% vs 13.38% median
    Revenue Growth (Trailing 4 Quarters, YoY)+4.01% vs +7.19% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 4.34% and EPS growth at 10.08% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+4.34%
    EPS Growth Forecast (2Y CAGR)+10.08%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OPCH

    What is OPCH's market cap?

    Option Care Health has a market cap of $4.75B. Its enterprise value, which adds debt and subtracts cash, is $5.61B.

    What is OPCH's P/E ratio?

    Option Care Health has a trailing P/E ratio of 18.5x and a forward P/E of 16.4x.

    How many shares of OPCH are outstanding?

    Option Care Health has 149.79M shares outstanding. The count is down 7.44% from a year earlier.

    Does OPCH pay a dividend?

    No. Option Care Health does not pay a dividend.

    How much debt does OPCH have?

    Option Care Health has $1.16B of total debt and $299.09M of cash and equivalents, a net debt position of $858.74M.